Connected Drug Delivery Devices Market Overview: 2025-2030
Base Year: 2024
Historical Years: 2020-23
Forecast Years: 2025-30
The Connected Drug Delivery Devices Market size is valued at USD 4.2 Billion in 2024 and is projected to reach USD 11 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 17% during the forecast period, i.e., 2025-30. This growth in the market is due to an increasing number of chronic diseases or NCDs such as diabetes, asthma, cardiovascular, etc. in the world today. According to the WHO, approximately 41 million people are killed every year by chronic diseases that make up about 71% of the overall deaths occurring around the world. Chronic disease cases are on a rise despite the increase in life expectancy rate with proper public healthcare facilities developed worldwide. Intake of substances like alcohol and tobacco contributes to major health hazards. Moreover, having a sedentary lifestyle also contributes to such increasing cases of chronic diseases all over the world. As per the estimates of WHO, at the current trend, by 2050 about 86% of all deaths will be from chronic diseases.
Markntel Advisor’s Connected Drug Delivery Devices Market Insights report provides the current and forecast market analysis, individual leading companies’ market shares, challenges, Connected Drug Delivery Devices Market drivers, barriers, Connected Drug Delivery Devices Market Trends, and Key Players in Connected Drug Delivery Devices Market.
Our Latest Reports Now Include In-Depth Supply Chain Ecosystem Analysis, Enabling Businesses to Navigate Tariff Challenges with Greater Agility Get Sample Report: https://www.marknteladvisors.com/query/request-sample/connected-drug-delivery-devices-market.html
Connected Drug Delivery Devices Market Dynamics: 2025-2030
Connected Drug Delivery Devices Market Driver
Rising Cases of Cardiovascular Diseases (CVD) – Globally, most of the deaths happen due to Chronic diseases. CVD is the leading cause of them, as these account for more than 30% of all deaths worldwide. The deaths attributed to CVD have moved up from approximately 12.1 million in 1990 to around 70% and have reached 20.5 million in 2021, reveals the World Heart Foundation. This growth is largely attributed to the increasing population all over the world. This is because globally, the death rate of CVD went down from 354.5 deaths per 100,000 people in 1990 to 239.9 deaths per 100,000 people in 2019. The decreasing birth rate globally which translates into a growing old-age population will raise the incidence of CVD further. The growing number of CVD cases will increase the demand for medication and rehabilitation associated with it. However, the optimum utilization of drugs for CVD is critically important for its effectiveness. Hence, the continuity and drug efficiency coupled with proper monitoring of daily dozes by the patient and the doctor will fuel the demand for connected drug delivery devices.
Browse Full Report with Detail Analysis – https://www.marknteladvisors.com/research-library/connected-drug-delivery-devices-market.html
Connected Drug Delivery Devices Market (2025-30): Segmentation Outlook
The market report has segmented the market into the following categories:
- By Device Type
- Connected Sensors Devices
- Inhalers- Market Size & Forecast 2020-2030, USD Million
- Injectors
- Auto-Injectors- Market Size & Forecast 2020-2030, USD Million
- Pen-Injectors- Market Size & Forecast 2020-2030, USD Million
- On-Body Connected Devices- Market Size & Forecast 2020-2030, USD Million
- Implanted Connected Devices- Market Size & Forecast 2020-2030, USD Million
- By Connectivity
- Bluetooth Enabled Devices- Market Size & Forecast 2020-2030, USD Million
- Near-Field Communication Enabled Devices- Market Size & Forecast 2020-2030, USD Million
- Cellular Enabled Devices- Market Size & Forecast 2020-2030, USD Million
- Wide Area Network Enabled Devices- Market Size & Forecast 2020-2030, USD Million
- By End User
- Hospitals- Market Size & Forecast 2020-2030, USD Million
- Clinics- Market Size & Forecast 2020-2030, USD Million
- Homecare- Market Size & Forecast 2020-2030, USD Million
- By Administration Route
- Parenteral- Market Size & Forecast 2020-2030, USD Million
- Inhalational- Market Size & Forecast 2020-2030, USD Million
- Homecare- Market Size & Forecast 2020-2030, USD Million
- By Application
- Chronic Diseases
- Asthma- Market Size & Forecast 2020-2030, USD Million
- Cardiovascular Diseases- Market Size & Forecast 2020-2030, USD Million
- Diabetes- Market Size & Forecast 2020-2030, USD Million
- Others- Market Size & Forecast 2020-2030, USD Million
- Personalized Medicines- Market Size & Forecast 2020-2030, USD Million
- Remote Patient Monitoring- Market Size & Forecast 2020-2030, USD Million
- Chronic Diseases
- By Region
- North America
- South America
- Europe
- The Middle East & Africa
- Asia-Pacific
- Connected Sensors Devices
Note – If there are any particular details you need that are not currently included in the report, we will be happy to provide them as part of our customization services.
Top Companies Operating in the Connected Drug Delivery Devices Market:
- Medtronic
- Insulet
- Tandem Diabetes Care
- Bigfoot Biomedical (Abbott)
- Phillips – Medisize
- West Pharmaceutical Services, Inc.
- Roche
- Becton Dickinson and Company
- Cohero Health Inc. (Aptar)
- Sagentia Innovation
- CeQur
- E3D Elcam Drug Delivery Devices
- BIOCORP
- Gerresheimer AG
- Ypsomed AG
- Nemera
- Others
Reports Delivery Format – Market research studies from MarkNtel Advisors are offered in PDF, Excel, and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address
About Us –
We are a leading market research company, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.
Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.
Contact Us –
Email: sales@marknteladvisors.com
Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511
Address Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India
